申请人:Idenix Pharmaceuticals, Inc.
公开号:US20140099283A1
公开(公告)日:2014-04-10
Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds are 2′-chloro nucleosides according to Formula 2001:
or a pharmaceutically acceptable salt, solvate, stereoisomeric form, tautomeric form or polymorphic form thereof, wherein B, Z and PD are as described herein.
本文提供了用于治疗黄病毒科感染,包括丙型肝炎感染的化合物、组合物和方法。在某些实施例中,揭示了核苷衍生物化合物和组合物,可以单独或与其他抗病毒药物联合给药。在某些实施例中,化合物是根据2001年公式的2'-氯核苷,或其药用可接受的盐、溶剂合物、立体异构体形式、互变异构体形式或多晶形式,其中B、Z和PD如本文所述。